52
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Cu2+-RGDFRGDS: exploring the mechanism and high efficacy of the nanoparticle in antithrombotic therapy

, , , , , , , , & show all
Pages 2925-2938 | Published online: 15 Apr 2015

References

  • ArnaoutMAGoodmanSLXiongJPComing to grips with integrin binding to ligandsCurr Opin Cell Biol200214564165112231361
  • LowellCAMayadasTNOverview: studying integrins in vivoMethods Mol Biol201275736939721909923
  • CampbellIDHumphriesMJIntegrin structure, activation, and interactionsCold Spring Harb Perspect Biol201133a00499421421922
  • MalkarNBLauer-FieldsJLJuskaDFieldsGBCharacterization of peptide-amphiphiles possessing cellular activation sequencesBiomacromolecules20034351852812741765
  • ConradiJHuberSGausKCyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1Amino Acids201243121923221915696
  • WangYWYangKTangHChenDBaiYLToxicity assessment of repeated intravenous injections of arginine-glycine-aspartic acid peptide conjugated CdSeTe/ZnS quantum dots in miceInt J Nanomedicine201494809481725378922
  • CoxRGLivesaySBJohnsonMOhiMDWilliamsJVThe human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrinsJ Virol20128622121481216022933271
  • FangWHeJKimYSZhouYLiuSEvaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444Bioconjug Chem20112281715172221780818
  • WangYYLüLXShiJCWangHFXiaoZDHuangNPIntroducing RGD peptides on PHBV films through PEG-containing cross-linkers to improve the biocompatibilityBiomacromolecules201112355155921294539
  • LinYPMcDonoughSPSharmaYChangYFLeptospira immunoglobulin-like protein B (LigB) binding to the C-terminal fibrinogen αC domain inhibits fibrin clot formation, platelet adhesion and aggregationMol Microbiol20117941063107621219469
  • AshinoTSudhaharVUraoNUnexpected role of the copper transporter ATP7A in PDGF-induced vascular smooth muscle cell migrationCirc Res2010107678779920671235
  • VosburghWCCooperGRComplex Ions I. The Identification of Complex Ions in Solution by Spectrophotometric MeasurementsJ Am Chem Soc1941632437442
  • DuncanCWhiteARCopper complexes as therapeutic agentsMetallomics20124212713822187112
  • YangMCuiGZhaoMThe effect of complexation of Cu(II) with P6A peptide and its analogs on their thrombolytic activitiesInt J Pharm20083621–2818718625295
  • RechesMGazitEMolecular self-assembly of peptide nanostructures: Mechanism of association and potential useCurr Nanosci200622105111
  • ChenYCuiGHZhaoMPengSQSynthesis nanoscale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-GluBioorg Med Chem200816115914592518495483
  • PlowEFHaasTAZhangLLoftusJSmithJWLigand binding to integrinsJ Biol Chem200027529217852178810801897
  • RajagopalKSchneiderJPSelf-assembling peptides and proteins for nanotechnological applicationsCurr Opin Struct Biol200414448048615313243
  • ChitnumsubPFioriWRLashuelHADiazHKellyJWThe nucleation of monomeric parallel beta-sheet-like structures and their self-assembly in aqueous solutionBioorg Med Chem199971395910199655
  • Łodyga-ChruścińskaEOłdziejSMiceraGImpact of 1,5-disubstituted tetrazole ring on chelating ability of delta-selective opioid peptideJ Inorg Biochem200498344745814987845
  • BorosERybak-AkimovaEHollandJPPycup – a bifunctional, cage-like ligand for (64)Cu radiolabelingMol Pharm201411261762924294970
  • LiNKangGGuiLNovel Cu(II)-RGD-octapeptides: Synthesis, coordination mode, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and correlation of sequence with nano-structureNanomedicine20117440340921272663
  • PoulsenTSKristensenSRKorsholmLVariation and importance of aspirin resistance in patients with known cardiovascular diseaseThromb Res2007120447748417188339
  • SeokJIJooISYoonJHCan aspirin resistance be clinically predicted in stroke patients?Clin Neurol Neurosurg2008110211011617964711
  • YangGZhaoMPengSThe application of tetrahydroisoquino-line-3-carbonyl-TARGD(F)F as an anti-thrombotic agent having dual mechanisms of actionMol Biosyst20128102672267922801714
  • KrishnapriyaKRSaravanakumarDArunkumarPKandaswamyMSynthesis of new oxamide-based ligand and its coordination behavior towards copper(II) ion: spectral and electrochemical studiesSpectrochim Acta A Mol Biomol Spectrosc20086941077108117690008
  • KlewpatinondMVilesJHEmpirical rules for rationalising visible circular dichroism of Cu2+ and Ni2+ histidine complexes: applications to the prion proteinFEBS Lett200758171430143417359979
  • ŐszKBókaBVárnagyKISóvágóaImreKurtánbTiborAntusSándorThe application of circular dichroism spectroscopy for the determination of metal ion speciation and coordination modes of peptide complexesPolyhedron2002212121492159
  • CucinottaVGiuffridaAMaccarroneGCoordination properties of 3-functionalized beta-cyclodextrins. Thermodynamic stereoselectivity of copper(II) complexes of the A,B-diamino derivative and its exploitation in LECEDalton Trans2005162731273616075113
  • AndersonFAJrSpencerFARisk factors for venous thromboembolismCirculation200310723 Suppl 1I9I1612814980
  • SilversteinMDHeitJAMohrDNPettersonTMO’FallonWMMeltonLJTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
  • van AkenBEden HeijerMBosGMvan DeventerSJReitsmaPHRecurrent venous thrombosis and markers of inflammationThromb Haemost200083453653910780312
  • van AkenBEReitsmaPHRosendaalFRInterleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosisBr J Haematol2002116117317711841414
  • WakefieldTWGreenfielLJRolfeMWInflammatory and procoagulant mediator interactions in an experimental baboon model of venous thrombosisThromb Haemost19936921641728456429
  • FoxAEKahnSRThe relationship between inflammation and venous thrombosis. A systematic review of clinical studiesThromb Haemost200594236236516113826
  • LippiGMontagnanaMDaneseEFavaloroEJFranchiniMGlyco-protein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacyBiomark Med201151637021319966
  • ChelliahRLuckingAJTattersallLP-selectin antagonism reduces thrombus formation in humansJ Thromb Haemost20097111915191919691482
  • WeyrichASElstadMRMcEverRPActivated platelets signal chemokine synthesis by human monocytesJ Clin Invest1996976152515348617886